Use of single-dose tocilizumab for treatment of severe COVID-19 in pregnancy: implications for the timing of live infant vaccines.

Burkhardt, Ingrid; Whittaker, Elizabeth

Burkhardt, Ingrid; Whittaker, Elizabeth.

Burkhardt I; Children's Services, Imperial College Healthcare NHS Trust, London, UK burkhardt.ingrid@gmail.com.
Whittaker E; Paediatrics, Imperial College Healthcare NHS Trust, London, UK.

Arch Dis Child ; 107(5): 517, 2022 05.

Article in English | MEDLINE | ID: covidwho-1673373

Subject(s)

COVID-19 Drug Treatment; Pregnancy Complications, Infectious; Antibodies, Monoclonal, Humanized/therapeutic use; Female; Humans; Infant; Pregnancy; Pregnancy Complications, Infectious/drug therapy; Vaccines, Attenuated

Keywords

allergy and immunology; infectious disease medicine; neonatology; paediatrics; therapeutics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pregnancy Complications, Infectious / COVID-19 Drug Treatment Topics: Vaccines Limits: Female / Humans / Infant / Pregnancy Language: English Journal: Arch Dis Child Year: 2022 Document Type: Article Affiliation country: Archdischild-2021-323628

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google